Bernards Rene 4
4 · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · Filed Oct 29, 2024
Insider Transaction Report
Form 4
Bernards Rene
Director
Transactions
- Award
Options to Purchase Common Stock
2024-09-30+5,304→ 5,304 totalExercise: $1.30From: 2024-09-30Exp: 2029-09-30→ Common (5,304 underlying)
Holdings
- 10,000
Options to Purchase Common Stock
Exercise: $2.37From: 2024-06-30Exp: 2029-06-30→ Common (10,000 underlying) - 4,149
Options to Purchase Common Stock
Exercise: $2.37From: 2024-06-30Exp: 2029-06-30→ Common (4,149 underlying)
Footnotes (1)
- [F1]Effective September 30, 2024, the reporting person was granted stock options to purchase an aggregate of 5,304 shares vesting immediately. The grant was in lieu of the quarterly cash compensation due to the reporting person under the Board Compensation Plan.